| dc.contributor.author | Estella García, Ángel | |
| dc.contributor.author | Cantón, María Luisa | |
| dc.contributor.author | Muñoz, Laura | |
| dc.contributor.author | Rodriguez Higueras, Isabel | |
| dc.contributor.author | Recuerda Núñez, María | |
| dc.contributor.author | Tejero Aranguren, Julia | |
| dc.contributor.author | Zaya, Benito | |
| dc.contributor.author | Gómez, Carmen | |
| dc.contributor.author | Amaya, Roario | |
| dc.contributor.author | Hurtado Martinez, Ángela | |
| dc.contributor.author | Odero Bernal, María del Valle | |
| dc.contributor.author | De la Fuente, Carmen | |
| dc.contributor.author | Alados Arboledas, Juan Carlos | |
| dc.contributor.author | Garnacho-Montero, José | |
| dc.contributor.other | Medicina | es_ES |
| dc.date.accessioned | 2022-09-12T11:59:56Z | |
| dc.date.available | 2022-09-12T11:59:56Z | |
| dc.date.issued | 2021-11 | |
| dc.identifier.issn | 2075-4426 | |
| dc.identifier.uri | http://hdl.handle.net/10498/27309 | |
| dc.description.abstract | Background: The aim of this study was to analyze the percentage of patients admitted to the ICU having received the vaccine against COVID-19, to describe the clinical profile of vaccinated patients admitted to the ICU, and to assess the humoral immune response to vaccination. Methods: In this multicenter prospective descriptive cohort study, consecutive critically ill patients with confirmed SARS-CoV-2 pneumonia who received at least one dose of the SARS-CoV-2 vaccine were included. The time of study was from 1 July to 10 August of 2021. Results: Of the 94 consecutive patients from seven Andalusian ICUs admitted during the time of study, 50 (53.2%) received at least one dose of anti SARS-CoV-2 vaccine. No patient was admitted having previously had SARS-CoV-2 infection. The B.1.617.2 (Delta) variant was the most frequently identified, in 80.76% of cases. Patients with a complete vaccination with non-optimal antibody levels were immunocompromised. Fifteen patients were admitted to the ICU with Acute Respiratory Distress Syndrome (ARDS) without having completed their vaccination; the clinical profile was younger and with less comorbidities compared to patients with full vaccination. There were no differences in severity of ARDS. Conclusions: Most of the patients who were admitted to the ICU having received a dose of the vaccine were not optimally vaccinated; fully vaccinated patients who did not obtain optimal serum antibody levels were patients considered immunocompromised | es_ES |
| dc.format | application/pdf | es_ES |
| dc.language.iso | eng | es_ES |
| dc.publisher | MDPI | es_ES |
| dc.rights | Atribución 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
| dc.source | Journal of Personalized Medicine, Vol. 11, Núm. 11 | es_ES |
| dc.subject | SARS-CoV-2 | es_ES |
| dc.subject | severe pneumonia | es_ES |
| dc.subject | acute respiratory distress syndrome | es_ES |
| dc.subject | vaccine | es_ES |
| dc.subject | ICU | es_ES |
| dc.subject | Delta variant SARS-CoV-2 | es_ES |
| dc.title | Vaccinated Patients Admitted in ICU with Severe Pneumonia Due to SARS-CoV-2: A Multicenter Pilot Study | es_ES |
| dc.type | journal article | es_ES |
| dc.rights.accessRights | open access | es_ES |
| dc.identifier.doi | 10.3390/jpm11111086 | |